Tech Company Financing Transactions
OpGen Funding Round
Private investors participated in a $2 million capital raise for OpGen. This venture round was announced on 12/30/2013.
Transaction Overview
Company Name
Announced On
12/30/2013
Transaction Type
Debt
Amount
$1,999,867
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for solicitation details, if applicable.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
708 Quince Orchard Rd.
Gaithersburg, MD 20878
USA
Gaithersburg, MD 20878
USA
Phone
Website
Email Address
Overview
OpGen (NASDAQ: OPGN) is a leading provider of genetic analysis services and systems. The company's proprietary Optical Mapping system (see technology) is used by academic and commercial organizations worldwide for applications including comparative genomics and genome sequence assembly/validation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Oliver Schacht
Chief Financial Officer
Timothy Dec
Chief Marketing Officer
Faranak Atrzadeh
Chief Operating Officer
Johannes Bacher
VP - Bus. Development
Chris Emery
VP - Regulatory Affairs
Autumn Collasius
Browse more venture capital transactions:
Prev: 12/30/2013: Manalto venture capital transaction
Next: 12/30/2013: GNS Healthcare venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs